Trial Profile
Efficacy of an HSV2 [herpes simplex virus] genital herpes suppressive treatment on HIV and HSV2 genital shedding among co-infected patients receiving or not antiretroviral drugs
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Feb 2010
Price :
$35
*
At a glance
- Drugs Valaciclovir (Primary)
- Indications Herpes simplex virus infections; HIV infections; HIV-1 infections
- Focus Pharmacodynamics; Therapeutic Use
- 22 Feb 2007 Results have been published
- 30 Oct 2006 New trial record.